The expression of both H2AZ isoforms was also significantly higher in high grade (Grade III and GBM) than low grade gliomas and non-tumors in the TCGA and NCI REMBRANDT datasets (Fig. 1C). This evidence concerns the gene H2AZ1 and central nervous system cancer.